F. Recker

Most-cited papers

1. Screening and prostate-cancer mortality in a randomized European study.

   F. Schröder, J. Hugosson, M. Roobol, T. Tammela +19 more

   2009New England Journal of Medicine4,039 citations Open access

   Semantic Scholar

   Save

2. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

   F. Schröder, J. Hugosson, M. Roobol, T. Tammela +25 more

   2014The Lancet1,536 citations Open access

   Semantic Scholar

   Save

3. Prostate Cancer Mortality at 11 years of Follow-up in the ERSPC

   FH Schröder, J. Hugosson, M. Roobol, T. Tammela +25 more

   2012New England Journal of Medicine1,265 citations Open access

   Semantic Scholar

   Save

4. “A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer”

   J. Hugosson, M. Roobol, M. Månsson, T. Tammela +27 more

   2019European Urology627 citations Open access

   Semantic Scholar

   Save

5. Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).

   F. Schröder, J. Hugosson, S. Carlsson, T. Tammela +5 more

   2012European Urology278 citations

   Semantic Scholar

   Save

6. Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

   M. Roobol, M. Kerkhof, F. Schröder, J. Cuzick +23 more

   2009European Urology225 citations

   Semantic Scholar

   Save

7. Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.

   E. Heijnsdijk, T. D. de Carvalho, Anssi Auvinen, M. Zappa +15 more

   2015Journal of the National Cancer Institute137 citations Open access

   Semantic Scholar

   Save

8. European Study of Prostate Cancer Screening - 23-Year Follow-up.

   M. Roobol, I. D. de Vos, M. Månsson, R. Godtman +19 more

   2025New England Journal of Medicine72 citations Open access

   Semantic Scholar

   Save

9. A Positive Family History as risk factor for Prostate Cancer in a Population-based Study with organized PSA-Screening: Results of the Swiss ERSPC (Aarau)

   M. Randazzo, A. Müller, S. Carlsson, D. Eberli +7 more

   2015BJU International49 citations Open access

   Semantic Scholar

   Save

10. Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer

    E. Olkhov‐Mitsel, T. van der Kwast, Ken J Kron, H. Ozçelik +8 more

    2012Epigenetics47 citations Open access

    Semantic Scholar

    Save

11. A "PSA pyramid" for men with initial prostate-specific antigen ≤3 ng/ml: a plea for individualized prostate cancer screening.

    M. Randazzo, J. Beatrice, A. Huber, R. Grobholz +4 more

    2015European Urology38 citations

    Semantic Scholar

    Save

12. Summary statement on screening for prostate cancer in Europe

    E. Heijnsdijk, C. Bangma, J. Borrás, T. D. de Carvalho +12 more

    2018International Journal of Cancer34 citations Open access

    Semantic Scholar

    Save

13. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.

    G. Giannarini, F. Birkhäuser, F. Recker, G. Thalmann +1 more

    2014European Urology33 citations

    Semantic Scholar

    Save

14. Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners.

    D. Seiler, M. Randazzo, Ulrich Leupold, N. Zeh +7 more

    2012Urology29 citations

    Semantic Scholar

    Save

15. Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

    S. Remmers, C. Bangma, R. Godtman, S. Carlsson +17 more

    2023European Urology28 citations Open access

    Semantic Scholar

    Save

16. Is further screening of men with baseline PSA < 1 ng ml−1 worthwhile? The discussion continues—Results of the Swiss ERSPC (Aarau)

    M. Randazzo, J. Beatrice, A. Huber, R. Grobholz +6 more

    2015International Journal of Cancer23 citations Open access

    Semantic Scholar

    Save

17. Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol‐based active surveillance: results from a contemporary European patient cohort

    D. Seiler, M. Randazzo, L. Klotz, R. Grobholz +4 more

    2012BJU International23 citations

    Semantic Scholar

    Save

18. Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau)

    M. Randazzo, J. Beatrice, A. Huber, R. Grobholz +5 more

    2015World journal of urology20 citations

    Semantic Scholar

    Save

19. Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?

    S. Carlsson, M. Månsson, S. Moss, M. Kwiatkowski +6 more

    2019European Urology16 citations Open access

    Semantic Scholar

    Save

20. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.

    L. Briollais, H. Ozçelik, Jing-Xiong Xu, M. Kwiatkowski +26 more

    2017Journal of the National Cancer Institute14 citations Open access

    Semantic Scholar

    Save

21. Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.

    M. Kwiatkowski, L. Klotz, J. Hugosson, F. Recker

    2012European Urology14 citations

    Semantic Scholar

    Save

22. A 16-year Follow-up of the European Randomized study of Screening for Prostate Cancer

    J. Hugosson, M. Roobol, M. Månsson, Teuvo +30 more

    201910 citations

    Semantic Scholar

    Save

23. Prevalence of joint, entheseal, tendon, and bursal findings in young, healthy individuals by musculoskeletal ultrasound

    J. Schreiner, D. Scheicht, P. Karakostas, F. Recker +5 more

    2021Scandinavian Journal of Rheumatology8 citations

    Semantic Scholar

    Save

24. PSA-Bestimmung Empfehlungen der Schweizerischen Gesellschaft für Urologie (SGU)

    T. Gasser, C. Iselin, P. Jichlinksi, B. Kreienbühl +7 more

    20128 citations Open access

    Semantic Scholar

    Save

25. A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center

    A. Becker, D. Seiler, M. Kwiatkowski, L. Kluth +7 more

    2014World journal of urology7 citations

    Semantic Scholar

    Save

26. Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau)

    L. Prause, L. Manka, C. Millan, E. Lang +7 more

    2019World journal of urology6 citations

    Semantic Scholar

    Save

27. ESICM LIVES 2016: part three : Milan, Italy. 1-5 October 2016.

    T. Velasquez, G. Mackey, J. Lusk, U. Kyle +496 more

    20165 citations

    Semantic Scholar

    Save

28. Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study

    A R N D K R R A E I S A C W K A R N S W A D K R R A Sgrò Blanco-Colino Brindl Chaudhry Gressmann Gujju, A. Sgrò, R. Blanco-Colino, N. Brindl +496 more

    2025British Journal of Surgery4 citations Open access

    Semantic Scholar

    Save

29. PSA-Test nicht geeignet zur Früherkennung des Prostatakarzinoms

    S. Wyler, M. Kwiatkowski, F. Recker

    20144 citations

    Semantic Scholar

    Save

30. 1011 DOES ACTIVE SURVEILLANCE LEAD TO INCREASED DISTRESS AND ANXIETY IN PARTNERS OF PROSTATE CANCER PATIENTS? DATA OF THE SWISS ERSPC-CENTER

    D. Seiler, N. Zeh, M. Randazzo, M. Schönberger +4 more

    20114 citations

    Semantic Scholar

    Save

31. 1934 PROSTATE SPECIFIC ANTIGEN (PSA)-PYRAMID IN MEN WITH LOW RANGE PSA: PROSTATE CANCER INCIDENCE AND MORTALITY - A PLEA FOR RISK-BASED PROSTATE CANCER SCREENING STRATEGY IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC), AARAU

    M. Randazzo, D. Seiler, J. Beatrice, M. Baumgartner +7 more

    20133 citations

    Semantic Scholar

    Save

32. Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies

    C. Wetterauer, J. Federer-Gsponer, F. Leboutte, Robin Mona +7 more

    2021Urologia internationalis2 citations Open access

    Semantic Scholar

    Save

33. Duplik

    F. Recker

    2019Schweizerische Ärztezeitung2 citations Open access

    Semantic Scholar

    Save

34. MP86-07 ASSOCIATION OF METFORMIN USE WITH PROSTATE CANCER INCIDENCE IN A PROSPECTIVE SCREENING TRIAL (ERSPC AARAU)

    M. Randazzo, T. Hermanns, C. Poyet, J. Beatrice +6 more

    20152 citations

    Semantic Scholar

    Save

35. Differences among Men on Active Surveillance for Very Low-Risk Prostate Cancer Detected Through Population-Based versus Opportunistic Prostate-Specific Antigen-Screening

    M. Randazzo, J. Beatrice, A. Huber, R. Grobholz +3 more

    2015Urologia internationalis2 citations

    Semantic Scholar

    Save

36. PSA-Screening 2013

    F. Recker, D. Seiler, B. Seifert, M. Randazzo +1 more

    2013Der Urologe2 citations

    Semantic Scholar

    Save

37. 663 THE HAROW STUDY- AN OBSERVATIONAL HEALTH SERVICE STUDY, CAPTURING CURRENT LOW-RISK-PROSTATE CANCER TREATMENT PRACTICE PATTERNS IN GERMANY

    A. Becker, D. Seiler, F. Recker, S. Beermann +2 more

    20132 citations

    Semantic Scholar

    Save

38. The Who, What, Why, and When of the American Board of Dental Specialties (ABDS).

    F. Recker

    2017Journal of Oral Implantology1 citations

    Semantic Scholar

    Save

39. MP39-15 SCREENING FOR PROSTATE CANCER: RESULTS FROM THE SWISS SECTION OF THE ERSPC (AARAU)

    M. Kwiatkowski, L. Prause, S. Wyler, Tilmann Moeltgen +4 more

    20161 citations Open access

    Semantic Scholar

    Save

40. Ultrasound education for medical students using e-learning and self-directed hands-on training

    N. Stauffert, D. Hempel, J. Schleifer, F. Recker +3 more

    20161 citations

    Semantic Scholar

    Save

41. Cortical and subcortical grey matter morphometry for neuroprognostication after cardiac arrest

    T. Velasquez, G. Mackey, J. Lusk, U. Kyle +496 more

    20161 citations Open access

    Semantic Scholar

    Save

42. 116 Family history as a risk factor for prostate cancer in a contemporary screening trial – results of the Swiss ERSPC (Aarau)

    M. Randazzo, J. Beatrice, C. Poyet, T. Hermanns +7 more

    20151 citations

    Semantic Scholar

    Save

43. 272 The HAROW study – an observational health service study, capturing current low-risk-prostate cancer treatment practice patterns in Germany

    A. Becker, L. Kluth, S. Beermann, D. Seiler +3 more

    20131 citations

    Semantic Scholar

    Save

44. PSA Bestimmung - Empfehlung der schweizerischen Gesellschaft für Urologie (SGU)

    T. Gasser, C. Iselin, P. Jichlinski, Beat Kreienbühl +7 more

    20121 citations

    Semantic Scholar

    Save

45. 785 Outcomes after various primary treatment for non-metastasised prostate cancer. A report from the European randomized screening trial for prostate cancer (ERSPC)

    S. Carlsson, S. Moss, A. Auvinen, L. Denis +7 more

    20121 citations

    Semantic Scholar

    Save

46. Dosage du PSA Recommandations de la Société suisse dUrologie (SSU)

    T. Gasser, C. Iselin, P. Jichlinksi, B. Kreienbühl +7 more

    20121 citations Open access

    Semantic Scholar

    Save

47. Health Outcomes Research Protocol-based Active Surveillance for Low-risk Prostate Cancer: Anxiety Levels in Both Men and Their Partners

    D. Seiler, M. Randazzo, Ulrich Leupold, N. Zeh +7 more

    20121 citations

    Semantic Scholar

    Save

48. 1009 ACTIVE SURVEILLANCE: THE EXPERIENCE OF THE SWISS ERSPC-CENTER

    D. Seiler, M. Randazzo, N. Zeh, M. Schönberger +3 more

    20111 citations

    Semantic Scholar

    Save

49. Das Mulchandani-Bhoj-Conlin Syndrom: eine wichtige Differentialdiagnose bei intrauteriner Wachstumsretardierung im zweiten Trimenon

    A. Dufke, G. Mielke, F. Recker, K. Grudzus +5 more

    2026Zeitschrift für Geburtshilfe und Neonatologie0 citations

    Semantic Scholar

    Save

50. AB1515 ASSESSMENT AND COMPARISON OF LONG-TERM SKILL RETENTION FOLLOWING TELEDIDACTIC MUSCULOSKELETAL ULTRASOUND TRAINING FOR MEDICAL STUDENTS – THE TELMUS FOLLOW-UP STUDY

    R. Neubauer, C. Bauer, S. Petzinna, F. Recker +1 more

    2024Scientific Abstracts0 citations

    Semantic Scholar

    Save